Literature DB >> 29623159

Diagnosing Ring-Enhancing Lesions in the Brain of a Patient With AIDS Without Brain Biopsy: A Case of Central Nervous System Histoplasmoma.

Rachel Beekman1, Jessica M Hu2, Steven I Aronin3, Maricar F Malinis4.   

Abstract

We report a case of a Puerto Rican male with advanced AIDS who presented with multiple falls and pancytopenia. Magnetic resonance imaging (MRI) of the brain, as initial workup, revealed 2 ring-enhancing brain lesions. Initial cerebrospinal fluid analysis revealed minimal cells, mildly elevated protein, and no organism seen on gram stain. Due to prohibitive thrombocytopenia, brain biopsy was deferred. He had neither clinical nor radiographic improvement despite empiric therapy for both toxoplasmosis and bacterial abscesses. Indicated by pancytopenia, bone marrow (BM) aspiration was performed. Culture of BM aspirate grew Histoplasma capsulatum. Urine histoplasma antigen was markedly elevated. He was treated with liposomal amphotericin B (LamB) for progressive disseminated histoplasmosis with probable central nervous system involvement. Cerebrospinal fluid histoplasma antigen obtained after 2 months of LamB was detected. After prolonged course of LamB, he took itraconazole. Brain MRI at 7-month follow-up revealed significant improvement from baseline study.

Entities:  

Keywords:  AIDS; brain abscess; central nervous system fungal infections; central nervous system infections; diagnosis; histoplasmosis

Year:  2017        PMID: 29623159      PMCID: PMC5882007          DOI: 10.1177/1941874417725969

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN: 1941-8744


  29 in total

Review 1.  Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature.

Authors:  L J Wheat; P A Connolly-Stringfield; R L Baker; M F Curfman; M E Eads; K S Israel; S A Norris; D H Webb; M L Zeckel
Journal:  Medicine (Baltimore)       Date:  1990-11       Impact factor: 1.889

2.  Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole.

Authors:  L Joseph Wheat; Patricia Connolly; Melinda Smedema; Michelle Durkin; Edward Brizendine; Paul Mann; Reena Patel; Paul M McNicholas; Mitchell Goldman
Journal:  J Antimicrob Chemother       Date:  2006-04-20       Impact factor: 5.790

3.  Magnetic resonance imaging findings in a patient with isolated histoplasma brain abscess.

Authors:  Anit Parihar; Vaishali Tomar; Bal K Ojha; Nuzhat Husain; Rakesh K Gupta
Journal:  Arch Neurol       Date:  2011-04

4.  Interleukin-4 influences the production of microfilariae in a mouse model of Brugia infection.

Authors:  Eileen Devaney; Victoria Gillan; Isla Wheatley; Jessica Jenson; Richard O'Connor; Paul Balmer
Journal:  Parasite Immunol       Date:  2002-01       Impact factor: 2.280

5.  Immune reconstitution syndrome in a patient with disseminated histoplasmosis and steroid taper: maintaining the perfect balance.

Authors:  Alison Jazwinski; Susanna Naggie; John Perfect
Journal:  Mycoses       Date:  2011-05       Impact factor: 4.377

6.  Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.

Authors:  M M Lederman; E Connick; A Landay; D R Kuritzkes; J Spritzler; M St Clair; B L Kotzin; L Fox; M H Chiozzi; J M Leonard; F Rousseau; M Wade; J D Roe; A Martinez; H Kessler
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

7.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

8.  Antifungal therapy for central nervous system histoplasmosis, using a newly developed intracranial model of infection.

Authors:  Ross R Haynes; Patricia A Connolly; Michelle M Durkin; Ann M LeMonte; Melinda L Smedema; Edward Brizendine; L Joseph Wheat
Journal:  J Infect Dis       Date:  2002-05-31       Impact factor: 5.226

9.  Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy.

Authors:  Mitchell Goldman; Robert Zackin; Carl J Fichtenbaum; Daniel J Skiest; Susan L Koletar; Richard Hafner; L Joseph Wheat; Peter M Nyangweso; Constantin T Yiannoutsos; Carol T Schnizlein-Bick; Susan Owens; Judith A Aberg
Journal:  Clin Infect Dis       Date:  2004-04-28       Impact factor: 9.079

10.  Disseminated histoplasmosis in acquired immunodeficiency syndrome patients in Uberaba, MG, Brazil.

Authors:  Delio José Mora; Celso Tadeu Barbosa dos Santos; Mario León Silva-Vergara
Journal:  Mycoses       Date:  2008-03       Impact factor: 4.377

View more
  1 in total

1.  "Pseudo CNS Sarcoidosis": Histoplasmosis of Brain Mimicking Steroid Refractory Sarcoidosis.

Authors:  Kaneez Zahra; Eric D Goldstein; Angela M Bohnen; William D Freeman
Journal:  Neurohospitalist       Date:  2019-11-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.